Kymera Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $511k | 20k | 25.46 |
| 2023-09-30 | $276k | 20k | 13.90 |
| 2023-06-30 | $402k | 18k | 22.99 |
| 2023-03-31 | $747k | 25k | 29.63 |
| 2022-12-31 | $524k | 21k | 24.96 |
| 2022-09-30 | $348k | 16k | 21.78 |
| 2022-06-30 | $397k | 20k | 19.69 |
| 2022-03-31 | $1.4M | 33k | 42.34 |
| 2021-12-31 | $2.3M | 36k | 63.47 |
| 2021-09-30 | $2.1M | 36k | 58.76 |
| 2021-06-30 | $933k | 19k | 48.84 |
| 2021-03-31 | $263k | 6.8k | 38.69 |
| 2020-12-31 | $463k | 7.4k | 62.50 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft